Sio Capital Management, LLC Mirati Therapeutics, Inc. Transaction History

Sio Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$41.99 - $62.38 $61 Million - $90.6 Million	1,451,925 New	1,451,925 $85.3 Million
Q4 2019 Feb 14, 2020	SELL	$70.76 - $128.86 $6.83 Million - $12.4 Million	-96,525 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$77.91 - $109.6 $3.02 Million - $4.25 Million	-38,775 Reduced 28.66%	96,525 $7.52 Million
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $4.67 Million - $8.22 Million	78,500 Added 138.2%	135,300 $13.9 Million
Q1 2019 May 15, 2019	BUY	$43.65 - $78.95 $2.48 Million - $4.48 Million	56,800 New	56,800 $4.16 Million
Q3 2018 Nov 14, 2018	SELL	$47.1 - $62.7 $2.83 Million - $3.77 Million	-60,050 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$26.05 - $52.4 $1.56 Million - $3.15 Million	60,050 New	60,050 $2.96 Million

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.